DJIA 16,805.41 127.51 0.76%
NASDAQ 4,483.72 30.92 0.69%
S&P 500 1,964.58 13.76 0.71%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

57.61 0.98 (1.73%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MRK $57.61 1.73%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $56.80
Previous Close $56.63
Daily Range $56.63 - $57.66
52-Week Range $44.62 - $61.33
Market Cap $166.2B
P/E Ratio 29.81
Dividend (Yield) $1.76 (3.1%)
Ex-Dividend Date
Dividend Pay Date
09/11/14
10/07/14
Volume 8,555,140
Average Daily Volume 11,258,276
Current FY EPS $3.48

Sector

Healthcare

Industry

Drugs

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

News & Commentary Rss Feed

Bristol-Myers Squibb Co's Third-Quarter Earnings Beat the Street

Bristol-Myers Squibb reported third-quarter earnings this morning. Here's what you need to know.

The Week Ahead In Earnings Reports: Pharmaceuticals

Will Merck (MRK) Pull a Surprise this Earnings Season? - Analyst Blog

Trade-Ideas: Merck (MRK) Is Today's Post-Market Leader Stock

Fast Money Halftime Report Final Trade From October 24

Pre-Market Earnings Report for October 27, 2014 : MRK, BEN, STX, ROP, HUN, TEN, AWI, PDS, EXAS, STN

Pre-Market Earnings Report for October 27, 2014 : MRK, BEN, STX, ROP, HUN, TEN, AWI, PDS, EXAS, STNG, EDR, SIR

Roche's Cancer Drug Sales Continue To Grow, May Face Competition In Medium Term

Merck Earnings Preview: Expect Continued Pressure On Topline Growth

Fab Four - Got To Get You Into My Life

Is Merck The Right Dividend Stock To Have In A Portfolio?

See More MRK News...

MRK's Top Competitors

MRK $57.61 (1.73%)
Current stock: MRK
NVS $90.15 (1.02%)
Current stock: NVS
PFE $29.11 (1.78%)
Current stock: PFE
JNJ $103.13 (0.49%)
Current stock: JNJ